Valganciclovir Therapy in Infants and Children With Congenital CMV Infection and Hearing Loss
Public ClinicalTrials.gov record NCT01649869. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II Randomized and Controlled Investigation of Six Weeks of Oral Valganciclovir Therapy in Infants and Children With Congenital Cytomegalovirus Infection and Hearing Loss
Study identification
- NCT ID
- NCT01649869
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Enrollment
- 54 participants
Conditions and interventions
Conditions
Interventions
- Placebo Other
- Valganciclovir Drug
Other · Drug
Eligibility (public fields only)
- Age range
- 1 Month to 4 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 23, 2015
- Primary completion
- Dec 23, 2019
- Completion
- Dec 23, 2019
- Last update posted
- Oct 15, 2024
2015 – 2019
United States locations
- U.S. sites
- 9
- U.S. states
- 8
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Children's of Alabama Child Health Research Unit (CHRU) | Birmingham | Alabama | 35233-0011 | — |
| Children's National Medical Center - Sheikh Zayed Campus - Infectious Disease | Washington D.C. | District of Columbia | 20010-2916 | — |
| Washington University School of Medicine in St. Louis - Center for Clinical Studies | St Louis | Missouri | 63110-1010 | — |
| Steven and Alexandra Cohen Childrens Medical Center of New York - New Hyde Park - Infectious Disease | Manhasset | New York | 11030-3816 | — |
| University of Rochester Medical Center | Rochester | New York | 14642-0001 | — |
| Carolinas Medical Center - Pediatrics - Infectious Diseases | Charlotte | North Carolina | 28203-5812 | — |
| Nationwide Children's Hospital - Neonatology - Center for Perinatal Research | Columbus | Ohio | 43205-2664 | — |
| Rhode Island Hospital - Pediatrics | Providence | Rhode Island | 02903-4923 | — |
| Texas Medical Center - Texas Children's Hospital | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01649869, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 15, 2024 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01649869 live on ClinicalTrials.gov.